Premium
Nipple‐sparing mastectomy with implant reconstruction: the Westmead experience
Author(s) -
Sood Samriti,
Elder Elisabeth,
French James
Publication year - 2015
Publication title -
anz journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.426
H-Index - 70
eISSN - 1445-2197
pISSN - 1445-1433
DOI - 10.1111/ans.12641
Subject(s) - medicine , seroma , mastectomy , breast cancer , surgery , adjuvant radiotherapy , implant , radiation therapy , cancer , complication
Background Nipple‐sparing mastectomy ( NSM ) involves the removal of all breast tissue with preservation of the breast skin envelope and nipple‐areola complex ( NAC ). The objective of this study was to report the outcomes from our initial experience with NSM . Methods We retrospectively analysed 87 women who underwent 118 NSMs between O ctober 2008 and M ay 2012. Results Indications for NSM were 60 (51%) primary cancer, 15 (13%) residual/recurrent disease, 39 (33%) risk reduction and 4 (3%) benign pathology. Implant loss ( n = 10) was associated with subcutaneous placement ( P = 0.01), post‐operative seroma and infection ( P = 0.028, 0.001), skin flap necrosis ( P = 0.007) and NAC loss ( P = 0.027). Capsular contraction was related to adjuvant radiotherapy ( P = 0.044). Local recurrence occurred in four patients, and NAC recurrence with invasive cancer occurred in one patient after a median follow‐up of 30 months. Conclusion Our A ustralian NSM series adds to the published literature supporting the oncological safety of NSM for early‐stage breast cancer and risk reduction.